Biomedical Engineering Reference
In-Depth Information
[38] Schakowski, F., Buttgereit, P., Mazur, M., Märten, A., Schöttker, B., Gorschlüter, M.,
& Schmidt-Wolf, I. G. (2004). Novel non-viral method for transfection of primary leu‐
kemia cells and cell lines. Genetic Vaccines and Therapy , 2(1), 1.
[39] Szeps, M., Erickson, S., Gruber, A., Castro, J., Einhorn, S., & Grandér, D. (2003). Ef‐
fects of interferon-alpha on cell cycle regulatory proteins in leukemic cells. Leukemia
and Lymphoma , 44(6), 1019-25.
[40] Finke, S., Trojaneck, B., Lefterova, P., Csipai, M., Wagner, E., Kircheis, R., Neubauer,
A., Huhn, D., Wittig, B., & Schmidt-Wolf, I. G. (1998). Increase of proliferation rate
and enhancement of antitumor cytotoxicity of expanded human CD3+ CD56+ immu‐
nologic effector cells by receptor-mediated transfection with the interleukin-7 gene.
Gene Therapy , 5(1), 31-9.
[41] Notter, M., Willinger, T., Erben, U., & Thiel, E. (2001). Targeting of a B7-1 (CD80) im‐
munoglobulin G fusion protein to acute myeloid leukemia blasts increases their cos‐
timulatory activity for autologous remission T cells. Blood , 97(10), 3138-45.
[42] Kato, K., Cantwell, MJ, Sharma, S., & Kipps, T. J. (1998). Gene transfer of CD40-li‐
gand induces autologous immune recognition of chronic lymphocytic leukemia B
cells. Journal of Clinical Investigation , 101(5), 1133-1141.
[43] Chowdhury, E. H., & Akaike, T. (2005). Bio-functional inorganic materials: an attrac‐
tive branch of gene-based nano-medicine delivery for 21st century. Current Gene
Therapy , 5, 669-676.
Search WWH ::




Custom Search